Full Length Research Paper
References
|
Aviram M, Rosenblat M, Billecke S, Erogul R, Sorenson R, Bisgaier CL, Newton RS, La Du B (1999). Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic. Biol. Med. 26 (7-8): 892-904. Crossref |
||||
|
Belcher JD, Marker RH, Geiger R, Girotti AW, Steinberg MH, Hebbel R, Vercellotti GM5 (1999). Low-density lipoprotein susceptibility to oxidation and cytotoxicity to endothelium in sickle cell anemia. J. Lab. Clin. Med.133:605-612. Crossref |
||||
|
Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ (1995). Atherosclerosis: basic mecha-nisms; oxidation, inflammation and genetics. Circulation 91 (9): 2488-2496. Crossref |
||||
|
Besler C, Heinrich K, Riwanto M, Lüscher TF, Landmesserb U (2010). High density lipoprotein-mediated anti-atherosclerotic and endothelial-protective effects: a potential novel therapeutic target in cardiovascular disease. Curr. Pharm. Des.16(13): 1480 – 1493. Crossref |
||||
| Bielicki JK, Forte TM (1999). Evidence that lipid hydroperoxides inhibit plasma lecithin:cholesterol acyltransferase activity. J. Lipid Res. 40(5): 948-954. | ||||
|
Chilsom GM, Hazen SI, Fox PL, Cathcart MK (1999). The oxidation of lipoproteins by monocytes-macrophages: biochemical and biological mechanisms. J. Biol. Chem. 274 (37): 25959-25962. Crossref |
||||
| Da luz PL, Favarato D, Faria-Neto Jr JR, Lemos P, Chagas ACP (2008). High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease. Clinics 64: 427-432. | ||||
|
Daugherty A, Roselaar SE (1995). Lipoprotein oxidation as a mediator of atherogenesis: insights from pharmacological studies. Cardiovasc. Res. 29 (3): 297-311. Crossref |
||||
|
Diatta A, Diallo F, Sarr NG, Traoré S, Diagne I, Sall PL, Sall ND, et Touré M (2002). Lésions peroxidatives des phospholides érythro-cytaires au cours de la drépanocytose. Dakar Médical 47 (1): 33-37. Pubmed |
||||
| Diatta A, Sall ND, Sarr GN, Diallo F et Touré M (1999). Évaluation du stress oxydatif dans la maladie drépanocytaire. L'Eurobiologiste 33 (241): 57-60 | ||||
|
El-hazmi MA, Jabbar FA, Warrys AS (1987). Cholesterol and trigly-ceride level in patients with sickle cell anaemia. Scand. J. Clin. Lab. Invest. 47(4): 351-354. Crossref |
||||
|
Fernandez ML, Webb D (2008). The LDL to HDL cholesterol ratio as a valuable tool to evaluate coronary heart disease risk. J. Am. Coll. Nutr. 27 (1): 1-5. Crossref |
||||
|
Filippatos TD, Elisaf MS (2013). High density lipoprotein and cardio-vascular diseases. World J. Cardiol. 5(7): 210-214. Crossref |
||||
|
Gotto AM Jr (1998). Triglyceride as a risk factor for coronary artery disease. Am. J. Cardiol. 82(9A):22Q-25Q. Crossref |
||||
|
Hebbel RP, Eaton JW, Balasingam M, Steinberg MH(1982). Sponta-neous oxygen radical generation by sickle erythrocytes. J. Clin. Invest. 70(6):1253-1259. Crossref |
||||
|
Hine D, Mackness B and Mackness M (2012).Coincubation of PON1, APO A1 and LCAT Increases the time HDL is able to prevent LDL oxidation. IUBMB Life 64(2): 157-161. Crossref |
||||
|
Huang H, Mai W, Liu D, Hao Y, Tao J, Dong Y (2008). The oxidation ratio of LDL: a predictor for coronary artery disease. Dis. Markers 24 (6): 341-349. Crossref |
||||
|
Ingram VM (1957). Gene mutations in human haemoglobin: the chemical difference between normal and sickle haemoglobin. Nature 180 (4581): 326–328 Crossref |
||||
|
Itabe H (2009). Oxidative modification of LDL: its pathological role in atherosclerosis. Clin. Rev. Allergy Immunol. 37(1): 4-11. Crossref |
||||
|
Kim CJ, Kim TH, Ryu WS, Ryoo UH (2000). Influence of menopause on High density lipoprotein-cholesterol and lipids. J. Korean Med. Sci. 15: 380-386. Pubmed |
||||
| Mokondjimobe E, Longo-Mbenza B, Ovono-Abessolo F, Gombet T, Guie G, Ngou-Milama E, Parra HJ (2012). Lipid, lipoproteins and atherogenesis profiles in sickle cell disease among Central African patients. Ann. Biol. Clin. (Paris) 70(2): 183-188. | ||||
|
Nagy L, Tontonoz P, Alvarez JGA, Chen H, Evans RM (1998). Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR-δ. Cell 93: 229-240. Crossref |
||||
|
Ngogang J, Mouray H, Lebreton De Vonne T, Raisonnier A (1989). Erythrocyte and plasma cholesterol exchange in sickle cell anemia. Clin. Chim. Acta. 179: 295-304. Crossref |
||||
|
Nnodim JK, Opara AU, Nwanjo HU, Ibeaja OA (2012). Plasma lipid profile in sickle cell disease patients in Oweri, Nigeria. Pak. J. Nutr. 11(1): 64-65. Crossref |
||||
|
Oztaz EY, Sabuncuoglu S, Unal S, Ozgunes N (2011). Hypocholes-terolemia is associated negatively with hemolysate lipid peroxidation in sickle cell anemia patients. Clin. Exp. Med. 11: 195-198. Crossref |
||||
|
Pauling L, Itano HA, Singer SJ, Wells IC (1949). Sickle cell anemia: a molecular disease. Science 110: 543-48. Crossref |
||||
|
Peluso I, Morabito G, Urban L, Loannone F, Serafini M (2012). Oxida-tive stress in atherosclerosis development: the central role of LDL and oxidative burst. Endocr. Metab. Immune Disord. Drug Targets 12(4): 351-360. Crossref |
||||
|
Rahimi Z, Merat A, Hagheshenas M, Madani H, Rezaei M, Nagel RL (2006). Plasma lipids in Iranians with sickle cell disease: hypocho-lesterolemia in sickle cell anemia and increase of HDL cholesterol in sickle cell trait. Clin. Chim. Acta 365: 217-220. Crossref |
||||
| Rice EC, Omorphos SC, Baysal E (1986). Sickle cell membranes and oxidative damage. Biochem. J. 237: 265-269. | ||||
|
Santamarina-Fojo S, Lambert G, Hoeg JM, Brewer HB (2000). Lecithin-cholesterol acyltransferase: role in lipoprotein metabolism, reverse cholesterol transport and atherosclerosis. Curr. Opin. Lipidol. 11: 267–275. Crossref |
||||
|
Seixas Mo, Rocha Lc, Carvalho Mb, Menezes JF, Lyra IM, Nascimento VML, Couto RD, Atta AM, Reis MG, Goncalves MS (2010). Levels of high-density lipoprotein cholesterol (HDL-C) among children with steady-state sickle cell disease. Lipids Health Dis. 9: 91. Crossref |
||||
|
Shores J, Peterson J, Vanderjagt D and Glew RH (2003). Reduced cholesterol levels in african-american adults with sickle cell disease. J. Natl. Med. Assoc. 95:813-817. PMid:14527048 PMCid:PMC2594470 |
||||
| Vanderjagt Dj, Shores J, Okorodudu A, Okolo SN, Glew RH (2001). Hypocholesterolemia in Nigerian children. J. Trop. Pediatr. 47:1-6 | ||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
